These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 18611717)
1. Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral dosage forms and in body fluids and tissue homogenates: a comparative study of sulbactam, clavulanic acid, ampicillin and amoxycillin. Wildfeuer A; Räder K Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S31-4. PubMed ID: 18611717 [TBL] [Abstract][Full Text] [Related]
2. [Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral formulations as well as in body fluids and tissue homogenates. Comparison of sulbactam, clavulanic acid, ampicillin and amoxicillin]. Wildfeuer A; Räder K Arzneimittelforschung; 1991 Jan; 41(1):70-3. PubMed ID: 2049115 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam. Sader HS; Tosin I; Sejas L; Miranda E Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase]. Moittie D; Simonet M; Veron M Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362 [TBL] [Abstract][Full Text] [Related]
5. Sulbactam and clavulanic acid: enzyme kinetics and synergy with ampicillin and mezlocillin. Cullmann W; Binder S; Stieglitz M Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S1-7. PubMed ID: 18611714 [TBL] [Abstract][Full Text] [Related]
6. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria]. Grimm H Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722 [TBL] [Abstract][Full Text] [Related]
7. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244. Thomson JM; Distler AM; Bonomo RA Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099 [TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteers. Hampel B; Lode H; Bruckner G; Koeppe P Drugs; 1988; 35 Suppl 7():29-33. PubMed ID: 3220007 [TBL] [Abstract][Full Text] [Related]
9. Implications of beta-lactamase-inhibitor combinations. Fuchs PC; Barry AL J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic properties of beta-lactamase inhibitors. de la Pena A; Derendorf H Int J Clin Pharmacol Ther; 1999 Feb; 37(2):63-75. PubMed ID: 10082170 [TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii]. López-Hernández S; Alarcón T; Delgado T; de Las Cuevas MC; López-Brea M Rev Esp Quimioter; 1999 Jun; 12(2):140-3. PubMed ID: 10562675 [TBL] [Abstract][Full Text] [Related]
12. Development of beta-lactamase inhibitors. Sutherland R J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512 [TBL] [Abstract][Full Text] [Related]
13. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains. Paniagua GL; Monroy E; García O; Vaca S Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741 [TBL] [Abstract][Full Text] [Related]
14. Oral bioavailability of ampicillin and amoxycillin alone and bound in fixed proportions to sulbactam and clavulanic acid. Desager JP; Costermans J; Van Nieuwenhuyze Y; Harvengt C J Int Med Res; 1989; 17(6):532-8. PubMed ID: 2628130 [TBL] [Abstract][Full Text] [Related]
15. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases. Grace ME; Fu KP; Gregory FJ; Hung PP Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368 [TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro studies on the beta-lactamase-inhibiting effect of clavulanic acid and sulbactam on ampicillin-resistant Enterobacteriaceae. Grimm H Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S9-S14. PubMed ID: 18611726 [TBL] [Abstract][Full Text] [Related]
17. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria. Nord CE J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398 [No Abstract] [Full Text] [Related]
18. [Comparative activity of oral beta-lactam antibiotics against fifty strains of Haemophilus influenzae producing a beta-lactamase according to bacterial inoculum]. Gaillot O; Simonet M Pathol Biol (Paris); 1994 May; 42(5):375-7. PubMed ID: 7824299 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis. Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333 [TBL] [Abstract][Full Text] [Related]
20. Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity. Hardin TC; Butler SC; Ross S; Wakeford JH; Jorgensen JH Pharmacotherapy; 1994; 14(2):147-52. PubMed ID: 8197032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]